See referenced original article on pages 3311–9, this issue.
Translational immunotherapeutics: Chemoimmunotherapy for malignant pleural mesothelioma
Article first published online: 2 JUL 2014
© 2014 American Cancer Society
Volume 120, Issue 21, pages 3268–3271, November 1, 2014
How to Cite
Adusumilli, P. S. (2014), Translational immunotherapeutics: Chemoimmunotherapy for malignant pleural mesothelioma. Cancer, 120: 3268–3271. doi: 10.1002/cncr.28883
- Issue published online: 20 OCT 2014
- Article first published online: 2 JUL 2014
- Manuscript Accepted: 12 MAY 2014
- Manuscript Received: 8 MAY 2014
Recent data indicate that chemotherapy treats cancer, at least in part, by facilitating an immune response to the tumor. The study results outlined in this issue highlight the potential benefits in devising an optimal strategy for integrating new immune-based therapies into the standard of care for various cancers.